Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

OTC wart removers

This article was originally published in The Tan Sheet

Executive Summary

FDA proposes a change in monograph labeling for OTC wart remover products containing 15% salicylic acid in a karaya gum, glycol plaster vehicle to include new directions for use. In a proposed rule appearing in the Jan. 28 Federal Register, FDA adds directions for use of an emery file and advises consumers to "apply a drop of warm water to the wart" prior to applying the medicated plaster. FDA noted that the only company currently marketing such a product has added these directions to product labeling. The agency said it is proposing the labeling change in order to avoid "consumer confusion" if other products, such as private labels, are using the current final monograph directions for use
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS082406

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel